Detalhe da pesquisa
1.
Antibody effector functions are associated with protection from respiratory syncytial virus.
Cell
; 185(26): 4873-4886.e10, 2022 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36513064
2.
Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine With an Adenovirus 26 Vector Encoding Prefusion F (Ad26.RSV.preF) in Adults Aged ≥60 Years.
J Infect Dis
; 222(6): 979-988, 2020 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32320465
3.
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial.
Ann Intern Med
; 164(5): 313-22, 2016 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26833336
4.
Persistence of immunological memory as a potential correlate of long-term, vaccine-induced protection against Ebola virus disease in humans.
Front Immunol
; 14: 1215302, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37727795
5.
Prime-boost vaccination with rBCG/rAd35 enhances CD8⺠cytolytic T-cell responses in lesions from Mycobacterium tuberculosis-infected primates.
Mol Med
; 18: 647-58, 2012 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-22396020
6.
Immunization by a bacterial aerosol.
Proc Natl Acad Sci U S A
; 105(12): 4656-60, 2008 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-18344320
7.
SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques.
Nat Commun
; 12(1): 5877, 2021 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34620860
8.
Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8 T-cell responses.
Immunology
; 129(4): 496-505, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20002212
9.
High content cellular immune profiling reveals differences between rhesus monkeys and men.
Immunology
; 131(1): 128-40, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20465573
10.
Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate.
NPJ Vaccines
; 5(1): 112, 2020 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33335092
11.
Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial.
EBioMedicine
; 7: 278-86, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27322481
12.
The safety and immunogenicity of an adenovirus type 35-vectored TB vaccine in HIV-infected, BCG-vaccinated adults with CD4(+) T cell counts >350 cells/mm(3).
Vaccine
; 33(15): 1890-6, 2015 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-25698492
13.
Human leukocyte antigens A*3001 and A*3002 show distinct peptide-binding patterns of the Mycobacterium tuberculosis protein TB10.4: consequences for immune recognition.
Clin Vaccine Immunol
; 18(1): 125-34, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21084459
14.
rBCG induces strong antigen-specific T cell responses in rhesus macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vector.
PLoS One
; 3(11): e3790, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-19023426
15.
Drying a tuberculosis vaccine without freezing.
Proc Natl Acad Sci U S A
; 104(8): 2591-5, 2007 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-17299039